{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:59:21Z","timestamp":1787497161099,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s41030-025-00301-6","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T03:37:45Z","timestamp":1749613065000},"page":"503-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Diagnostic Approach to Malignant Pleural Mesothelioma"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0859-5550","authenticated-orcid":false,"given":"Avinash","family":"Aujayeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Astoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"301_CR1","doi-asserted-by":"publisher","unstructured":"Woolhouse I, Bishop L, Darlison L, et al. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma. Thorax 2018;73:i1-i30 https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211321","DOI":"10.1136\/thoraxjnl-2017-211321"},{"key":"301_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12885-025-13914-6","volume":"25","author":"B Zou","year":"2025","unstructured":"Zou B, Wu P, Chen J, et al. The global burden of cancers attributable to occupational factors, 1990\u20132021. BMC Cancer. 2025;25:503.","journal-title":"BMC Cancer"},{"key":"301_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107828","volume":"193","author":"AL Frank","year":"2024","unstructured":"Frank AL, van Zandwijk N. Asbestos history and use. Lung Cancer. 2024;193: 107828. https:\/\/doi.org\/10.1016\/j.lungcan.2024.107828.","journal-title":"Lung Cancer"},{"key":"301_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jtho.2022.03.012","volume":"17","author":"S Laaksonen","year":"2022","unstructured":"Laaksonen S, Kettunen E. Sutinen, E et al. Pulmonary asbestos fiber burden is related to patient survival in malignant pleural mesothelioma. J Thorac Oncol. 2022;17:1032\u201341.","journal-title":"J Thorac Oncol"},{"key":"301_CR5","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/thoraxjnl-2013-203744","volume":"69","author":"A Lacourt","year":"2014","unstructured":"Lacourt A, Gramond C, Rolland P, et al. Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma. Thorax. 2014;69:532\u20139.","journal-title":"Thorax"},{"key":"301_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jtho.2023.01.095","volume":"18","author":"J Huang","year":"2023","unstructured":"Huang J, Chan SC, Pang WS, et al. Global incidence, risk factors, and temporal trends of mesothelioma: a population-based study. J Thorac Oncol. 2023;18:792\u2013802.","journal-title":"J Thorac Oncol"},{"issue":"8","key":"301_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/CLEP.S105396","volume":"26","author":"JL Beebe-Dimmer","year":"2016","unstructured":"Beebe-Dimmer JL, Fryzek JP, Yee CL, et al. Mesothelioma in the United States: a surveillance, epidemiology, and end results (SEER)-Medicare investigation of treatment patterns and overall survival. Clin Epidemiol. 2016;26(8):743\u201350. https:\/\/doi.org\/10.2147\/CLEP.S105396.","journal-title":"Clin Epidemiol"},{"key":"301_CR8","doi-asserted-by":"crossref","unstructured":"Conway, R.J.; Smith, N.; Cooper, W et al. on behalf of the ASSESS-meso Collaborative group. Reflecting real-world patients with mesothelioma in research: An interim report of baseline characteristics from the ASSESS-meso cohort.\u00a0ERJ Open Res.\u00a02023,\u00a09, 00467\u20132023.","DOI":"10.1183\/23120541.00467-2023"},{"issue":"9","key":"301_CR9","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.3390\/curroncol31090368","volume":"31","author":"E Roca","year":"2024","unstructured":"Roca E, Aujayeb A, Astoul P. Diagnosis of pleural mesothelioma: Is everything solved at the present time? Curr Oncol. 2024;31(9):4968\u201383. https:\/\/doi.org\/10.3390\/curroncol31090368.","journal-title":"Curr Oncol"},{"key":"301_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/medicina55080490","volume":"55","author":"K Skok","year":"2019","unstructured":"Skok K, Hladnik G, Grm A, Crnjac A. Malignant pleural effusion and its current management: a review. Medicina. 2019;55:490. https:\/\/doi.org\/10.3390\/medicina55080490.","journal-title":"Medicina"},{"issue":"3","key":"301_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2214\/ajr.154.3.2106209","volume":"154","author":"AN Leung","year":"1990","unstructured":"Leung AN, M\u00fcller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol. 1990;154(3):487\u201392. https:\/\/doi.org\/10.2214\/ajr.154.3.2106209.","journal-title":"AJR Am J Roentgenol"},{"key":"301_CR12","doi-asserted-by":"crossref","unstructured":"Roberts\u00a0ME,\u00a0Rahman\u00a0NM,\u00a0Maskell\u00a0NA\u00a0On behalf of the BTS Pleural Guideline Development Group, et al. British Thoracic Society Guideline for pleural disease Thorax\u00a02023;78:s1-s42","DOI":"10.1136\/thorax-2022-219784"},{"issue":"1","key":"301_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0720-048x(01)00426-0","volume":"41","author":"M Metintas","year":"2002","unstructured":"Metintas M, Ucgun I, Elbek O, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol. 2002;41(1):1\u20139. https:\/\/doi.org\/10.1016\/s0720-048x(01)00426-0.","journal-title":"Eur J Radiol"},{"key":"301_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.lungcan.2018.01.014","volume":"118","author":"S Tsim","year":"2018","unstructured":"Tsim S, Humphreys CA, Cowell GW, et al. Early contrast enhancement: a novel magnetic resonance imaging biomarker of pleural malignancy. Lung Cancer. 2018;118:48\u201356. https:\/\/doi.org\/10.1016\/j.lungcan.2018.01.014.","journal-title":"Lung Cancer"},{"key":"301_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.lungcan.2012.10.017","volume":"79","author":"E Roca","year":"2013","unstructured":"Roca E, Laroumagne S. Vandemoortele T et a 18F-Fluoro-2-Deoxy-D-glucose positron emission tomography\/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough. Lung Cancer. 2013;79:187\u201390. https:\/\/doi.org\/10.1016\/j.lungcan.2012.10.017.","journal-title":"Lung Cancer"},{"key":"301_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1159\/000381922","volume":"89","author":"V Pinelli","year":"2015","unstructured":"Pinelli V, Roca E. Lucchini S et al. Positron emission tomography\/computed tomography for the pleural staging of malignant pleural mesothelioma: How accurate is it? Respiration. 2015;89:558\u201364. https:\/\/doi.org\/10.1159\/000381922.","journal-title":"Respiration"},{"key":"301_CR17","doi-asserted-by":"publisher","unstructured":"Gill RR, Nowak AK, Giroux DJ, et al. Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards and Participating Institution. The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the \"T\" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma. J Thorac Oncol. 2024 Sep;19(9):1310\u20131325. https:\/\/doi.org\/10.1016\/j.jtho.2024.03.007","DOI":"10.1016\/j.jtho.2024.03.007"},{"key":"301_CR18","doi-asserted-by":"publisher","unstructured":"Bille A, Ripley RT, Giroux DJ, et al. Members of the Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions. The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the \"N\" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma. J Thorac Oncol. 2024 Sep;19(9):1326\u20131338. https:\/\/doi.org\/10.1016\/j.jtho.2024.05.003.","DOI":"10.1016\/j.jtho.2024.05.003"},{"key":"301_CR19","doi-asserted-by":"publisher","unstructured":"Nowak AK, Giroux DJ, Eisele M, et al. Members of the Staging and Prognostic Factors Committee of the Advisory Boards and Participating Institutions. The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Proposal for Revision of the TNM Stage Groupings in the Forthcoming (Ninth) Edition of the TNM Classification for Pleural Mesothelioma. J Thorac Oncol. 2024 Sep;19(9):1339\u20131351. https:\/\/doi.org\/10.1016\/j.jtho.2024.05.002.","DOI":"10.1016\/j.jtho.2024.05.002"},{"key":"301_CR20","unstructured":"IASLC Staging Reference Cards, 9th Edition, https:\/\/www.iaslc.org\/research-education\/publications-resources-guidelines\/staging-cards-thoracic-oncology-9th-edition. Accessed 21\/03\/2025"},{"issue":"1","key":"301_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2024-002840","volume":"12","author":"AE Stanton","year":"2025","unstructured":"Stanton AE, Juniper M. Bedawi E, et al. Pleural procedural safety in the UK: is everyone\u2019s house in order? Reflections from the BTS National Pleural Service Organisational Audit and a national review of patient safety incidents. BMJ Open Respir Res. 2025;12(1): e002840. https:\/\/doi.org\/10.1136\/bmjresp-2024-002840.","journal-title":"BMJ Open Respir Res"},{"key":"301_CR22","doi-asserted-by":"publisher","first-page":"1801254","DOI":"10.1183\/13993003.01254-2018","volume":"52","author":"DT Arnold","year":"2018","unstructured":"Arnold DT, De Fonseka D, Perry S, et al. Investigating unilateral pleural effusions: The role of cytology. Eur Respir J. 2018;52:1801254. https:\/\/doi.org\/10.1183\/13993003.01254-2018.","journal-title":"Eur Respir J"},{"key":"301_CR23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.chest.2022.11.019","volume":"163","author":"A Sundaralingam","year":"2023","unstructured":"Sundaralingam A, Aujayeb A, Akca B, et al. Achieving molecular profiling in pleural biopsies: a multicenter. Retrospective Cohort Study Chest. 2023;163:1328\u201339. https:\/\/doi.org\/10.1016\/j.chest.2022.11.019.","journal-title":"Retrospective Cohort Study Chest"},{"issue":"6","key":"301_CR24","doi-asserted-by":"publisher","first-page":"E254","DOI":"10.3978\/j.issn.2072-1439.2013.11.28","volume":"5","author":"N van Zandwijk","year":"2013","unstructured":"van Zandwijk N, Clarke C, Henderson D, et al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013;5(6):E254\u2013307. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2013.11.28.","journal-title":"J Thorac Dis"},{"issue":"1","key":"301_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000511626","volume":"100","author":"F Mei","year":"2021","unstructured":"Mei F, Bonifazi M, Rota M, Cirilli L, et al. Diagnostic yield and safety of image-guided pleural biopsy: a systematic review and meta-analysis. Respiration. 2021;100(1):77\u201387. https:\/\/doi.org\/10.1159\/000511626.","journal-title":"Respiration"},{"key":"301_CR26","unstructured":"STREAMLINE - Health Research Authority, https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/streamline\/ Accessed 21\/03\/2025"},{"key":"301_CR27","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3390\/healthcare10101978","volume":"10","author":"D Li","year":"2022","unstructured":"Li D, Jackson K, Panchal R, Aujayeb A. Local anaesthetic thoracoscopy for pleural effusion\u2014a narrative review. Healthcare. 2022;10:1978. https:\/\/doi.org\/10.3390\/healthcare10101978.","journal-title":"Healthcare"},{"key":"301_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.lungcan.2019.05.017","volume":"133","author":"S Tsim","year":"2019","unstructured":"Tsim S, Paterson S, Cartwright D, et al. Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting \u201cDirect to LAT\u201d in selected groups. Lung Cancer. 2019;133:123\u20139. https:\/\/doi.org\/10.1016\/j.lungcan.2019.05.017.","journal-title":"Lung Cancer"},{"issue":"1","key":"301_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/medsci11010023","volume":"11","author":"M Turner","year":"2023","unstructured":"Turner M, Craighead F, MacKenzie JD, et al. Day case local anaesthetic thoracoscopy: experience from 2 district general hospitals in the United Kingdom. Med Sci (Basel). 2023;11(1):23. https:\/\/doi.org\/10.3390\/medsci11010023.","journal-title":"Med Sci (Basel)"},{"issue":"Suppl 4","key":"301_CR30","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.3978\/j.issn.2072-1439.2015.11.66","volume":"7","author":"S Shojaee","year":"2015","unstructured":"Shojaee S, Lee HJ. Thoracoscopy: medical versus surgical-in the management of pleural diseases. J Thorac Dis. 2015;7(Suppl 4):S339\u201351. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2015.11.66.","journal-title":"J Thorac Dis"},{"issue":"11","key":"301_CR31","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.5858\/arpa.2023-0304-RA","volume":"148","author":"AN Husain","year":"2024","unstructured":"Husain AN, Chapel DB. Attanoos R et al. Guidelines for pathologic diagnosis of mesothelioma: 2023 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med. 2024;148(11):1251\u201371. https:\/\/doi.org\/10.5858\/arpa.2023-0304-RA.","journal-title":"Arch Pathol Lab Med"},{"key":"301_CR32","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3390\/jcm10112434","volume":"10","author":"G Rossi","year":"2021","unstructured":"Rossi G, Davoli F, Poletti V, et al. When the diagnosis of mesothelioma challenges textbooks and guidelines. J Clin Med. 2021;10:2434. https:\/\/doi.org\/10.3390\/jcm10112434.","journal-title":"J Clin Med"},{"key":"301_CR33","doi-asserted-by":"publisher","unstructured":"Farkas JR, Sharobim M, Schulte JJ. Updates on the pathologic diagnosis and classification of mesothelioma. J Cancer Metastasis Treat. 2022;8:37. https:\/\/doi.org\/10.20517\/2394-4722.2022.89","DOI":"10.20517\/2394-4722.2022.89"},{"issue":"Suppl 1","key":"301_CR34","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.21037\/tlcr.2019.11.29","volume":"9","author":"DB Chapel","year":"2020","unstructured":"Chapel DB, Schulte JJ, Husain AN, et al. Application of immunohistochemistry in diagnosis and management of malignant mesothelioma. Transl Lung Cancer Res. 2020;9(Suppl 1):S3\u201327. https:\/\/doi.org\/10.21037\/tlcr.2019.11.29.","journal-title":"Transl Lung Cancer Res"},{"key":"301_CR35","unstructured":"Aligning a Pleural Service with GIRFT recommendations, https:\/\/www.respiratoryfutures.org.uk\/features\/aligning-a-pleural-service-with-girft-recommendations\/#:~:text=The%20GIRFT%20recommendations%20focus%20on,achieves%20the%20Best%20Practice%20Tariff. [Accessed 22\/03\/2025]"},{"key":"301_CR36","doi-asserted-by":"publisher","unstructured":"Brims F, Gunatilake S, Lawrie I, et al. RESPECT-Meso investigators. Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial. Thorax. 2019 Apr;74(4):354\u2013361. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212380","DOI":"10.1136\/thoraxjnl-2018-212380"},{"key":"301_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/jor2030011","volume":"2","author":"L Taylor","year":"2022","unstructured":"Taylor L, Swainston K. Hurst, C et al. Health and lifestyle of patients with mesothelioma: protocol for the help-meso study. J Respir. 2022;2:129\u201338. https:\/\/doi.org\/10.3390\/jor2030011.","journal-title":"J Respir"},{"key":"301_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/09699260.2022.2158286","author":"C Gardiner","year":"2022","unstructured":"Gardiner C, Harrison M. Hargreaves S et al. Palliative care roles and responsibilities of mesothelioma clinical nurse specialists in the UK. Progress in Palliative Care. 2022. https:\/\/doi.org\/10.1080\/09699260.2022.2158286.","journal-title":"Progress in Palliative Care"},{"issue":"11","key":"301_CR39","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41416-020-01078-y","volume":"123","author":"SV Harden","year":"2020","unstructured":"Harden SV, Darlison L, Beckett P, et al. Standards of care in mesothelioma treatment. Br J Cancer. 2020;123(11):1588\u20139. https:\/\/doi.org\/10.1038\/s41416-020-01078-y. (Epub 2020 Sep 22).","journal-title":"Br J Cancer"},{"issue":"9","key":"301_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012092","volume":"6","author":"AC Bibby","year":"2016","unstructured":"Bibby AC, Williams K, Smith S, et al. What is the role of a specialist regional mesothelioma multidisciplinary team meeting? A service evaluation of one tertiary referral centre in the UK. BMJ Open. 2016;6(9): e012092. https:\/\/doi.org\/10.1136\/bmjopen-2016-012092.","journal-title":"BMJ Open"},{"key":"301_CR41","doi-asserted-by":"publisher","unstructured":"Tate M, Roche J, Tsim S et al. The Scottish Mesothelioma Network: Impact of a national MDT on overall survival in pleural mesothelioma European Respiratory Journal 2023; 62(suppl 67): OA1560; https:\/\/doi.org\/10.1183\/13993003.congress-2023.OA1560","DOI":"10.1183\/13993003.congress-2023.OA1560"},{"key":"301_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107832","volume":"193","author":"SG Armato 3rd","year":"2024","unstructured":"Armato SG 3rd, Katz SI, Frauenfelder T, et al. Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2024;193: 107832.","journal-title":"Lung Cancer"},{"issue":"23","key":"301_CR43","first-page":"318","volume":"22","author":"I Barreto","year":"2024","unstructured":"Barreto I, Franckenberg S, Frauenfelder T, et al. Potential advantage of magnetic resonance imaging in detecting thoracic wall infiltration in pleural mesothelioma: a retrospective single-center analysis. JTCVS Open. 2024;22(23):318\u201325.","journal-title":"JTCVS Open"},{"issue":"3","key":"301_CR44","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jtho.2022.11.018","volume":"18","author":"SI Katz","year":"2023","unstructured":"Katz SI, Straus CM, Roshkovan L, et al. Considerations for imaging of malignant pleural mesothelioma: a consensus statement from the international mesothelioma interest group. J Thorac Oncol. 2023;18(3):278\u201398.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"301_CR45","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/diagnostics12030750","volume":"12","author":"F Volpi","year":"2022","unstructured":"Volpi F, D\u2019Amore CA, Colligiani L, Milazzo A, Cavaliere S, et al. The use of chest magnetic resonance imaging in malignant pleural mesothelioma diagnosis. Diagnostics (Basel). 2022;12(3):750.","journal-title":"Diagnostics (Basel)"},{"issue":"17","key":"301_CR46","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.3390\/cancers13174377","volume":"13","author":"C Romei","year":"2021","unstructured":"Romei C, Fanni SC, Volpi F, Milazzo A, D\u2019Amore CA, et al. New updates of the imaging role in diagnosis, staging, and response treatment of malignant pleural mesothelioma. Cancers (Basel). 2021;13(17):4377.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"301_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1053\/j.semnuclmed.2025.02.001","volume":"55","author":"M Badarna","year":"2025","unstructured":"Badarna M, Keidar Z, Arnon-Sheleg E. Current and future perspective of PET\/CT in response assessment of malignant pleural mesothelioma. Semin Nucl Med. 2025;55(2):252\u201363.","journal-title":"Semin Nucl Med"},{"key":"301_CR48","doi-asserted-by":"publisher","unstructured":"Fjaellegaard K, Koefod Petersen J, Reuter S et al. Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis. Lung Cancer. 2021 Dec;162:106\u2013118. https:\/\/doi.org\/10.1016\/j.lungcan.2021.10.018.","DOI":"10.1016\/j.lungcan.2021.10.018"},{"key":"301_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejrad.2019.04.003","volume":"115","author":"DJ Murphy","year":"2019","unstructured":"Murphy DJ, Mak SM, Mallia A, et al. Loco-regional staging of malignant pleural mesothelioma by integrated 18F-FDG PET\/MRI. Eur J Radiol. 2019;115:46\u201352.","journal-title":"Eur J Radiol"},{"issue":"15","key":"301_CR50","doi-asserted-by":"publisher","first-page":"408","DOI":"10.18632\/oncotarget.28594","volume":"20","author":"K Kitajima","year":"2024","unstructured":"Kitajima K, Kuribayashi K, Minami T, et al. Comparison of FDG-PET\/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma. Oncotarget. 2024;20(15):408\u201317.","journal-title":"Oncotarget"},{"issue":"22","key":"301_CR51","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.3390\/jcm12227006","volume":"12","author":"C Sorino","year":"2023","unstructured":"Sorino C, Mondoni M, Marchetti G, et al. Pleural mesothelioma: advances in blood and pleural biomarkers. J Clin Med. 2023;12(22):7006.","journal-title":"J Clin Med"},{"issue":"9","key":"301_CR52","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3390\/diagnostics12092210","volume":"12","author":"Z Lu","year":"2022","unstructured":"Lu Z, Zhang W, Huang K, Zhu M, et al. Systematic review, meta-analysis and bioinformatic analysis of biomarkers for prognosis of malignant pleural mesothelioma. Diagnostics (Basel). 2022;12(9):2210.","journal-title":"Diagnostics (Basel)"},{"issue":"16","key":"301_CR53","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.3390\/cancers13163932","volume":"13","author":"L Castelletti","year":"2021","unstructured":"Castelletti L, Yeo D, van Zandwijk N, et al. Anti-Mesothelin CAR T cell therapy for malignant mesothelioma. Cancers (Basel). 2021;13(16):3932.","journal-title":"Cancers (Basel)"},{"key":"301_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.lungcan.2021.01.011","volume":"154","author":"SI Katz","year":"2021","unstructured":"Katz SI, Roshkovan L, Berger I, Friedberg JS, Alley EW, et al. Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial. Lung Cancer. 2021;154:5\u201312.","journal-title":"Lung Cancer"},{"issue":"6","key":"301_CR55","doi-asserted-by":"publisher","first-page":"1700919","DOI":"10.1183\/13993003.00919-2017","volume":"50","author":"K Lamote","year":"2017","unstructured":"Lamote K, Vynck M, Thas O, et al. Exhaled breath to screen for malignant pleural mesothelioma: a validation study. Eur Respir J. 2017;50(6):1700919.","journal-title":"Eur Respir J"},{"issue":"4","key":"301_CR56","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7163\/ad7166","volume":"18","author":"LD Little","year":"2024","unstructured":"Little LD, Barnett SE, Issitt T, et al. Volatile organic compound analysis of malignant pleural mesothelioma chorioallantoic membrane xenografts. J Breath Res. 2024;18(4): 046010.","journal-title":"J Breath Res"},{"key":"301_CR57","doi-asserted-by":"crossref","unstructured":"Zwijsen K, Schillebeeckx E, Janssens E, Cleemput JV, Richart T, et al. Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results. J Breath Res. 2023 Sep 21;17(4).","DOI":"10.1088\/1752-7163\/acf7e3"},{"issue":"2","key":"301_CR58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/mi14020391","volume":"14","author":"H Kiss","year":"2023","unstructured":"Kiss H, \u00d6rl\u0151s Z, Gell\u00e9rt \u00c1, Megyesfalvi Z, Mik\u00e1cz\u00f3 A, et al. Exhaled biomarkers for point-of-care diagnosis: recent advances and new challenges in breathomics. Micromachines (Basel). 2023;14(2):391.","journal-title":"Micromachines (Basel)"},{"key":"301_CR59","doi-asserted-by":"publisher","first-page":"1900953","DOI":"10.1183\/13993003.00953-2019","volume":"55","author":"A Scherpereel","year":"2020","unstructured":"Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, et al. ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J. 2020;55:1900953.","journal-title":"Eur Respir J"},{"issue":"1","key":"301_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4046\/trd.2024.0029","volume":"88","author":"NC Huan","year":"2025","unstructured":"Huan NC, Kho SS, Nyanti LE, et al. Dry medical thoracoscopy with artificial pneumothorax induction using Veress needle. Tuberc Respir Dis (Seoul). 2025;88(1):181\u20139. https:\/\/doi.org\/10.4046\/trd.2024.0029.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"301_CR61","doi-asserted-by":"publisher","unstructured":"Tamburrini M, Desai U, Fanti G, et al. Medical thoracoscopy without pleural fluid: How I do it. Monaldi Arch Chest Dis. 2021 Jul 22;92(1). https:\/\/doi.org\/10.4081\/monaldi.2021.1331","DOI":"10.4081\/monaldi.2021.1331"},{"issue":"9","key":"301_CR62","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1111\/crj.12940","volume":"12","author":"J Janssen","year":"2018","unstructured":"Janssen J, Maldonado F, Metintas M. What is the significance of non-specific pleuritis? A trick question Clin Respir J. 2018;12(9):2407\u201310. https:\/\/doi.org\/10.1111\/crj.12940.","journal-title":"A trick question Clin Respir J"},{"issue":"3","key":"301_CR63","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ejcts\/ezr086","volume":"41","author":"O Pikin","year":"2012","unstructured":"Pikin O, Filonenko E, Mironenko D, et al. Fluorescence thoracoscopy in the detection of pleural malignancy. Eur J Cardiothorac Surg. 2012;41(3):649\u201352. https:\/\/doi.org\/10.1093\/ejcts\/ezr086.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"301_CR64","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.chest.2019.04.090","volume":"156","author":"L Wijmans","year":"2019","unstructured":"Wijmans L, Baas P, Sieburgh TE, et al. Confocal laser endomicroscopy as a guidance tool for pleural biopsies in malignant pleural mesothelioma. Chest. 2019;156(4):754\u201363. https:\/\/doi.org\/10.1016\/j.chest.2019.04.090.","journal-title":"Chest"},{"issue":"2","key":"301_CR65","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/resp.13945","volume":"26","author":"O Bonhomme","year":"2021","unstructured":"Bonhomme O, Heinen V. Detrembleur N et al. Probe-based confocal laser endomicroscopy for pleural malignancies diagnosis. Respirology. 2021;26(2):188\u201395. https:\/\/doi.org\/10.1111\/resp.13945.","journal-title":"Respirology"},{"issue":"10","key":"301_CR66","doi-asserted-by":"publisher","first-page":"1196000","DOI":"10.3389\/fmed.2023.1196000","volume":"9","author":"H Wang","year":"2023","unstructured":"Wang H, Liu Y, Wang J, et al. Rapid on-site evaluation of touch imprints of medical thoracoscopy biopsy tissue for the management of pleural disease. Front Med (Lausanne). 2023;9(10):1196000. https:\/\/doi.org\/10.3389\/fmed.2023.1196000.","journal-title":"Front Med (Lausanne)"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00301-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-025-00301-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-025-00301-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:06:55Z","timestamp":1757185615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-025-00301-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1007\/s41030-025-00301-6","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Avinash Aujayeb is an Editorial Board member of Pulmonary Therapy. Avinash Aujayeb was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Philippe Astoul has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}